OFI Invest Asset Management’s West Pharmaceutical WST Stock Holding History

OFI Invest Asset Management’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$439K	Buy	1,224 +107	+10%	+$32.7K	﹤0.01%	315
2026 Q1	$280K	Sell	1,117 -71,441	-98%	-$17.8M	﹤0.01%	312
2025 Q4	$17M	Buy	+72,558	New	+$19.8M	0.24%	102
2025 Q2	–	Sell	-3,527	Closed	-$731K	–	377
2025 Q1	$731K	Sell	3,527 -315	-8%	-$86.8K	0.02%	215
2024 Q4	$1.22M	Buy	+3,842	New	+$1.21M	0.03%	188
2024 Q2	$1.16M	Buy	3,786 +3,700	+4,302%	+$1.31M	0.03%	174
2024 Q1	$31.5K	Buy	86 +17	+25%	+$6.29K	﹤0.01%	231
2023 Q4	$22K	Buy	69 +1	+1%	+$354	﹤0.01%	283
2023 Q3	$24.1K	Buy	+68	New	+$26.3K	﹤0.01%	253

Other funds holding WST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

OFI Invest Asset Management's WST Position: Q2 2026 in Review

OFI Invest Asset Management increased its West Pharmaceutical (WST) stake by 9.6% in Q2 2026, buying an estimated $32.7K and bringing the position to 1,224 shares worth $439K. The position accounts for ﹤0.01% of the portfolio, ranked #315.

OFI Invest Asset Management first reported a position in WST in Q3 2023 and has held it in 9 quarters since. The position peaked at $17M in Q4 2025. 834 funds tracked by Wall St. Rank hold WST as of Q2 2026.

OFI Invest Asset Management held 1,224 shares of West Pharmaceutical worth $439K as of Q2 2026.
OFI Invest Asset Management bought 107 West Pharmaceutical shares in Q2 2026, an estimated $32.7K.
West Pharmaceutical made up ﹤0.01% of OFI Invest Asset Management's portfolio in Q2 2026, its #315 holding.
OFI Invest Asset Management first reported a position in West Pharmaceutical in Q3 2023 and has held it in 9 quarters since.
OFI Invest Asset Management's West Pharmaceutical position peaked at $17M in Q4 2025.
834 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on OFI Invest Asset Management's 13F filing for Q2 2026, filed 17 Jul 2026.